Pacific Biosciences of California, Inc. Third Quarter 2020 Financial Results Call

MENLO PARK, Calif., Oct. 19, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Third Quarter 2020 Financial Results on Monday, November 2, 2020, at 4:30pm Eastern Time.The call will be webcast and may be accessed at Pacific Biosciences’ website at: https://investor.pacificbiosciences.com/.Date: November 2,... Read more

Bruker Introduces PaSER™ Software for ‘Run and Done’ 4D- ProteomicsTM and TIMS/PASEF Method Wins HUPO 2020 Award

HUPO 2020 Science and Technology Award for Commercialization of TIMS Technology True Single Cell 1,000 Protein Group Results from Mann Lab leverage dia-PASEF® and further improvements in ultra-low flow Evosep chromatography and modified TIMS/PASEF set-up Significant Improvements in Quantitative Targeted 4D-Proteomics with prm-PASEF® Licensing of PhoX cross-linker from Heck Lab enables caps-PASEF structural proteomics BILLERICA,... Read more

Dr. Amy Liao Receives the Wallace A. Coulter Award for Healthcare Innovation

Dr. Amy Liao Receives the Wallace A. Coulter Award for Healthcare Innovation CHELMSFORD, Mass., Oct. 16, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) announced today that Dr. Amy Liao, president of Brooks Life Science Services, has received the Biomedical Engineering Society’s Wallace A. Coulter award for innovation in healthcare.  The Coulter award recognizes an outstanding... Read more

Xylem Inc. Declares Fourth Quarter Dividend of 26 Cents Per Share

RYE BROOK, N.Y.–(BUSINESS WIRE)–Oct. 15, 2020– The Board of Directors of Xylem Inc. (NYSE: XYL) has declared a fourth quarter dividend of $0.26 per share payable on December 3, 2020 to shareholders of record as of November 5, 2020. Xylem is a leading global water technology company committed to developing innovative solutions to the world’s... Read more

Xylem to release third quarter 2020 financial results on October 29, 2020

RYE BROOK, N.Y.–(BUSINESS WIRE)–Oct. 14, 2020– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, will release its third quarter 2020 results at 6:55 a.m. (ET) on Thursday, October 29, 2020. At 10:00 a.m. (ET), Xylem’s senior management team will host a conference call with investors.... Read more

QIAGEN reports strong preliminary results for third quarter of 2020

Venlo, The Netherlands, October 13, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today preliminary sales and adjusted earnings per share (EPS) results for the third quarter of 2020.  Net sales grew 26% at actual rates, and also rose 26% at constant exchange rates (CER), to $481.3 million from $382.7 million in the same period... Read more

MTS Receives Outstanding Achievement Award for Workplace Safety

EDEN PRAIRIE, Minn., Oct. 12, 2020 /PRNewswire/ — MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of advanced test systems, motion simulators and precision sensors, today announced receipt of an award recognizing outstanding results in workplace health and safety. MTS will receive an Outstanding Achievement Award from the Minnesota Safety Council during the Governor’s Safety... Read more

GE Healthcare Receives FDA Clearance for Vivid Ultra Edition, AI-Powered Cardiovascular Ultrasound System Designed to Shorten Diagnostic Exam Time and Improve Measurement Consistency

Chicago (October 12, 2020) – GE Healthcare today announced U.S. FDA 510k clearance for its Ultra Edition package on Vivid[1] cardiovascular ultrasound systems, which includes new features based on artificial intelligence (AI) that enable clinicians to acquire faster, more repeatable exams consistently. Methodical assessments of heart function are key in echocardiography but can be tedious... Read more

PerkinElmer Updates Third Quarter Outlook; To Hold Earnings Call on Wednesday, October 28, 2020

WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 12, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it anticipates reported and organic revenue growth of approximately 35% and 33%, respectively, for the third quarter ended October 4, 2020. The strong revenue growth performance was driven by continued better-than-expected demand for PerkinElmer’s... Read more

CORRECTING and REPLACING PerkinElmer Updates Third Quarter Outlook; To Hold Earnings Call on Wednesday, October 28, 2020

WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 12, 2020– The table in the release was incorrect. The corrected table should read: PerkinElmer, Inc: PerkinElmer, Inc. and SubsidiariesRECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (1)     PKI Three Months Ended October 4, 2020 Organic revenue growth: Reported revenue growth 35% Less: effect of foreign exchange rates 1% Less: effect... Read more